Cutaneous Adverse Reaction – Friday Pop Quiz – 11/16

The patient developed this cutaneous adverse reaction 2 weeks after starting a clinical trial medication. What is the mechanism of action of the culprit medication?

A). Epidermal growth factor receptor (EGFR) inhibitor
B.) Tumor necrosis factor (TNF)-alpha inhibitor
C.) Smoothened inhibitor
D.) BRAF inhibitor
E.) Programmed cell death (PD)-1 inhibitor

To find out the correct answer and read the explanation, click here.

Brought to you by our Brand Partner
Derm In-Review